BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05445778-completion@plaintrial.com
DTSTAMP:20261027T000216Z
DTSTART;VALUE=DATE:203205
SUMMARY:Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Ma
 intenance in Platinum-sensitive Epithelial Ovarian\, Fallopian Tube\, or P
 eritoneal Cancer — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05445778
URL:https://plaintrial.com/trial/NCT05445778
END:VEVENT
END:VCALENDAR